Skip to main content

Table 1 Demography and predisposing factors of patients with cellulitis

From: Factors associated with sepsis development in 606 Spanish adult patients with cellulitis

 All
n = 606
No sepsis
(n = 541)
Sepsis
(n = 65)
P value
Demography & anthropometry
 Gender
  Male314 (51.8%)276 (51.0%)38 (58.5%)0.3
  Female292 (48.2%)265 (49.0%)27 (41.5%) 
 Age (years)63.43 (61.85–65.05)63.42 (61.76–65.12)63.53 (58.29–69.22)1
 Body mass index (kg/m2)
  (n = 350)30.00 (29.25–30-77)30.05 (29.28–30.83)29.58 (26.73–32.73)0.7
Predisposing factors / comorbidities
 Prior cellulitis
  Yes156 (25.7%)139 (25.7%)17 (26.2%)0.9
  No450 (74.3%)402 (74.3%)48 (73.8%) 
 Episodes of prior cellulitis
  (Only if prior cellulitis)1.72 (1.56–1.90)1.71 (1.54–1.89)1.86 (1.32–2.61)0.6
 Episodes of prior cellulitis
  0450 (74.3%)402 (74.3%)48 (73.8%)0.4
  179 (13.0%)71 (13.1%)8 (12.3%) 
  227 (4.5%)24 (4.4%)3 (4.6%) 
  326 (4.3%)25 (4.6%)1 (1.5%) 
  4 or more24 (4.0%)19 (3.5%)5 (7.7%) 
 Location of prior cellulitis
  Same location143 (91.7%)129 (92.8%)14 (82.4%)0.15
  Other locations13 (8.3%)10 (7.2%)3 (17.6%) 
 Prior wounds
  Yes332 (54.8%)295 (54.5%)37 (56.9%)0.7
  No274 (45.2%)54.5% (45.5%)28 (43.1%) 
 Type of wound
  None274 (45.2%)246 (45.5%)28 (43.1%)0.8
  Skin ulcer110 (18.2%)96 (17.7%)14 (21.5%) 
  Non-surgical trauma108 (17.8%)94 (17.4%)14 (21.5%) 
  Surgical34 (5.6%)32 (5.9%)2 (3.1%) 
  Animal bite12 (2.0%)12 (2.2%)0 (0.0%) 
  Injection11 (1.8%)9 (1.7%)2 (3.1%) 
  Arthropod bite11 (1.8%)10 (1.8%)1 (1.5%) 
  Others46 (7.6%)42 (7.8%)4 (6.2%) 
 Prior skin lesions
  Yes182 (30.0%)164 (30.3%)18 (27.7%)0.7
  No424 (70.0%)377 (69.7%)47 (72.3%) 
 Diabetes
  Yes153 (25.2%)131 (24.2%)22 (33.8%)0.09
  No453 (74.8%)410 (75.8%)43 (66.2%) 
 Varices
  Yes124 (20.5%)112 (20.7%)12(18.5%)0.7
  No482 (79.5%)429 (79.3%)53 (81.5%) 
 Prior deep venous thrombosis
  Yes23 (3.8%)21 (3.9%)2 (3.1%)0.9
  No583 (95.9%)520 (96.1%)63 (96.9%) 
 Edema / lymphedema
  Yes168 (27.7%)151 (27.9%)17 (26.2%)0.8
  No438 (72.3%)390 (72.1%)48 (73.8%) 
 Heart failure
  Yes101 (16.7%)90 (16.6%)11 (16.9%)1
  No505 (83.3%)451 (83.4%)54 (83.1%) 
 Obesity
  Yes229 (37.8%)208 (38.4%)21 (32.3%)0.3
  No377 (62.2%)333 (61.6%)44 (67.7%) 
 Immunosuppression
  Yes70 (11.6%)62 (11.5%)8 (12.3%)0.8
  No536 (88.4%)479 (88.5%)57 (87.7%) 
 Intravenous drug use
  Yes7 (1.2%)7 (1.3%)0 (0.0%)1
  No599 (98.8%)534 (98.7%)65 (100%) 
 HIV infection
  Yes10 (1.7%)10 (1.8%)0 (0.0%)0.6
  No596 (98.3%)531 (98.2%)65 (100%) 
 Other comorbidities
  Yes452 (74.6%)398 (73.6%)54 (83.1%)0.096
  No154 (25.4%)143 (26.4%)11 (16.9%) 
  1. Values are expressed as mean (95% CI) or % as appropriate